The effect of recombinant human hyaluronidase on dexamethasone penetration into the posterior segment of the eye after sub-tenon's injection

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 5, 2006, Pages 362-369

  Kozak, Igor ^a   Kayikcioglu, Ozcan R ^a   Cheng, Lingyun ^a   Falkenstein, Iryna ^a   Silva, Gabriel A ^a   Yu, Diana X ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENEBORONIC ACID; DEXAMETHASONE; HYALURONIDASE; HYDROXYAPATITE; RECOMBINANT HUMAN HYALURONIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CHOROID; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG PENETRATION; DRUG TISSUE LEVEL; ENUCLEATION; HISTOLOGY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INJECTION; ION EXCHANGE CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; POSTERIOR EYE CHAMBER; PROTEIN PURIFICATION; RABBIT; RETINA; SERUM; SUBTENON INJECTION; VITREOUS BODY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DEXAMETHASONE; DRUG COMBINATIONS; DRUG INTERACTIONS; EYE; HUMANS; HYALURONOGLUCOSAMINIDASE; INJECTIONS; PERMEABILITY; RABBITS; RECOMBINANT PROTEINS;

EID: 33750682050     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.362     Document Type: Article

References (29)

1. Kurz, D., and Ciulla, T.A. Novel approaches for retinal drug delivery. Ophthalmol. Clin. N. Am. 15:405-410, 2002.
2. Lang, J.C. Ocular drug delivery conventional ocular formulations. Adv. Drug Deliv. Rev. 16:39-43, 1995.
3. Olsen, T.W., Aaberg, S.Y., Geroski, D.H., et al. Human sclera: Thickness and surface area. Am. J. Ophthalmol. 125:237-241, 1998.
4. Jaissle, G.B., Szurman, P., Bartz-Schmidt, K.U. Ocular side-effects and complications of intravitreal triamcinolone acetonide injection. Ophthalmologe 101(2):121-128, 2004.
5. Moshfeghi, D.M., Kaiser, P.K., and Scot, I.U. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am. J. Ophthalmol. 136(5):791-796, 2003.
6. Weijtens, O., Schoemaker, R.C., Lentjies, E.G., et al. Dexamethasone concentration in the subretinal fluid after a subconjunctival injection, a peribulbar injection, or an oral dose. Ophthalmology 107:1932-1938, 2000.
7. Weijtens, O., van der Sluijs, P.A., Schoemaker, R.C., et al. Peribulbar corticosteroid injection: Vitreal and serum concentrations after dexamethasone disodium phosphate injection. Am. J. Ophthalmol. 123:358-363, 1997.
8. Freeman, W.R., Green, R.L., and Smith, R.E. Echographic localization of corticosteroids after periocular injection. Am. J. Ophthalmol. 103(3):281-288, 1987.
9. Maurice, D.M., and Polgar, J. Diffusion acroos the sclera. Exp. Eye Res. 25:577-582, 1977.
10. Gehlbach, P., Demetriades, A.M., Yamamoto, S., et al. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization. Gene Ther. 10:637-646, 2003.
11. Geroski, D.H., Edelhauser, H.F., et al. Transscleral drug delivery for posterior segment disease. Adv. Drug Del. Rev. 52:37-48, 2001.
12. Lee, S.B., Geroski, D.H., Prausnitz, M.R., et al. Drug delivery through the sclera: Effects of thickness, hydration, and sustained release systems. Exp. Eye Res. 78:559-607, 2004.
13. Cruysberg, L.P., Nuijts, R.M., Geroski, D.H., et al. In vitro human scierai permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein, and rhodamine 6G and the use of a coat coil as a new drug delivery system. J. Ocul. Pharm. Ther. 18:559-569, 2002.
14. Boubriak, O.A., Urban, J.P.G., and Bron, A.J. Differential effects of aging on transport properties of anterior and posterior human sciera. Exp. Eye Res. 76:701-713, 2003.
15. Olsen, T.W. Human scleral permeability: Effects of age, cryotherapy, trans-scleral diode laser, and surgical thinning. Inv. Ophth. Vis. Sci. 36:1893-1903, 1995.
16. Barza, M., Kane, A., and Baum, J.L. Regional differences in ocular concentration of gentamicin after subconjunctival and retrobulbar injection in the rabbit. Am. J. Ophthalmol. 83:407-413, 1977.
17. Lim, J.I., Maguire, A.M., John, G., et al. Intraocular tissue plasminogen activator concentrations after subconjunctival delivery. Ophthalmology 100:373-376, 1993.
18. Lincoff, H., Stanga, P., Movshovich, A., et al. Choroidal concentration of interferon after retrobulbar injection. Invest. Ophthnlmol. Vis. Sci. 37:2768-2771, 1996.
19. Lam, T.T., Fu, J., and Tso, M.O. A histopathologic study of retinal lesions inflicted by transscleral ion-tophoresis. Graefe's Arch. Clin. Exp. Ophthalmol. 229:389-394, 1991.
20. Behar-Cohen, F.F., El Aouni, A., Gautier, S., et al. Trans-scleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: Influence of duration of treatment, current intensity, and drug concentration on ocular tissue and fluid levels. Exp. Eye Res. 74:51-59, 2002.
21. Okabe, K., Kimura, H., Okabe, J., et al. Effect of benzalkonium chloride on trans-scleral drug delivery. Invest. Ophthnlmol. Vis. Sci. 46(2):703-708, 2005.
22. Watson, D. Hyaluronidase. Br. J. Anesth. 71:422-425, 1993.
23. Ahluwalia, H.S., Lukaris, A., and Lane, C.M. Delayed allergic reaction to hyaluronidase: A rare sequel to cataract surgery. Eye 17:263-266, 2003.
24. Eberhart, A.H., Weiler, C.R., and Erie, J.C. Angioedema related to the use of hyaluronidase in cataract surgery. Am. J. Ophthalmol. 138(1):142-143, 2004.
25. Quhill, F., Bowling, B., and Packard, R.B. Hyaluronidase allergy after peribulbar anesthesia with orbital inflammation J. Cataract Refract. Surg. 30:916-917, 2004.
26. Frost, G.I., Csoka, T.B., Wong, T., et al. Purification, cloning, and expression of human plasma hyaluronidase. Biochem. Biophys. Res. Comm. 236:10-15, 1997.
27. Tate, D.J., Jr., Oliver, P.D., Miceli, M.V., et al. Age-dependent change in the hyaluronic acid content of the human chorioretinal complex. Arch. Ophthalmol. 111(7):963-967, 1993.
28. Hollyfield, J.G., Rayborn, M.E., and Tammi, R. Hyaluronan localization in tissues of the mouse posterior eye wall: Absence in the interphotoreceptor matrix. Exp. Eye Res. 65(5):603-608, 1997.
29. Edelhauser, H.F., and Ubels, J.L. The cornea and the sclera. In: Kaufman, P.L., and Alm, A., (Eds), Adler's Physiology of the Eye, 10th ed. St. Louis, MO: Mosby, 2003:97-103.